The Therapeutical Role of Continuous Intra-femoral Artery Infusion of Urokinase on Diabetic Foot Ulcers

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT01108120

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01108120
Other papers using this trial's data
  • Continuous intrafemoral artery infusion of urokinase improves diabetic foot ulcers healing and decreases cardiovascular events in a long-term follow-up study BMJ open diabetes research & care, 2024-01-12 DOI, PubMed 38216296, PMC10806882 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01108120. Randomized; no masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2022-12-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Therapeutical Role of Continuous Intra-femoral Artery Infusion of Urokinase on Diabetic Foot Ulcers
Condition
Diabetic Foot Ulcer
Intervention (Drug)
continuous intra-femoral thrombolysis group
Intervention (Drug)
Conventional therapy group
Lead sponsor
Xiang Guang-da (class: other)

Record details

Record id
cardio:ct-nct01108120
Content hash
b8fe614569863b864e774b04f5ee4706bf0428d17830cb942753495ff7cc8552